SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001437749-24-009050 from cbdMD, Inc. (YCBD)

cbdMD, Inc.
Date: March 22, 2024 · CIK: 0001644903 · Accession: 0001437749-24-009050

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-277124

Date
March 22, 2024
Author
/s/ T. Ronan Kennedy
Form
CORRESP
Company
cbdMD, Inc.

Letter

ycbd20240322_corresp.htm

cbdMD, Inc.

2101 Westinghouse Blvd., Suite A

Charlotte, NC

March 22, 2024

Via EDGAR

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, N.E.

Washington, D. C. 20549

Re:

cbdMD, Inc.

Registration Statement on Form S-1

File No. 333-277124

Ladies and Gentlemen:

In accordance with Rule 461 promulgated pursuant to the Securities Act of 1933, cbdMD, Inc. is hereby requesting that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:30 p.m. on Tuesday, March 26, 2024, or as soon thereafter as is practicable.

If you have any questions regarding this request, please contact either Brian Pearlman or Brian Bernstein, our legal counsel, at (954) 880-9484.

Very truly yours,
/s/ T. Ronan Kennedy

Show Raw Text
CORRESP
1
filename1.htm

	ycbd20240322_corresp.htm

cbdMD, Inc.

2101 Westinghouse Blvd., Suite A

Charlotte, NC

28273

March 22, 2024

Via EDGAR

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, N.E.

Washington, D. C. 20549

			Re:

			cbdMD, Inc.

			Registration Statement on Form S-1

			File No.           333-277124

Ladies and Gentlemen:

In accordance with Rule 461 promulgated pursuant to the Securities Act of 1933, cbdMD, Inc. is hereby requesting that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:30 p.m. on Tuesday, March 26, 2024, or as soon thereafter as is practicable.

If you have any questions regarding this request, please contact either Brian Pearlman or Brian Bernstein, our legal counsel, at (954) 880-9484.

			Very truly yours,

			/s/ T. Ronan Kennedy

			T. Ronan Kennedy

			Interim Chief Executive Officer

cc:

Brian A. Pearlman, Esq.

Brian S. Bernstein, Esq.